Cargando…

Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant?

Detalles Bibliográficos
Autores principales:	Chhibba, Tarun, Targownik, Laura E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813199/ https://www.ncbi.nlm.nih.gov/pubmed/35123675 http://dx.doi.org/10.1016/S2468-1253(22)00040-1

Ejemplares similares

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

Blunted humoral response after mRNA vaccine in patients with haematological malignancies
por: Kamboj, Mini
Publicado: (2021)

TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
por: Schäfer, Arne, et al.
Publicado: (2023)

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
por: Robinson, Philip C, et al.
Publicado: (2020)

Culturally relevant COVID-19 vaccine acceptance strategies in sub-Saharan Africa
por: Ajeigbe, Olufunke, et al.
Publicado: (2022)

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Is precision medicine relevant in the age of COVID-19?
por: Zhou, Amy, et al.
Publicado: (2021)

Comment on “Multibacillary leprosy unmasked by COVID-19 vaccination”
por: Hanumanthu, Vinod, et al.
Publicado: (2022)

Kinetics of cellular and humoral responses to third COVID-19 vaccine in heart transplant recipients: Correspondence
por: Sokaromdee, Pathum, et al.
Publicado: (2022)

MERS-CoV in Africa—an enigma with relevance to COVID-19
por: Perlman, Stanley, et al.
Publicado: (2021)

Responsive and agile vaccination strategies against COVID-19 in India
por: Mandal, Sandip, et al.
Publicado: (2021)

The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022)

Never say “never the twain shall meet”: Combining antiretroviral therapy and RNA vaccine to obtain an adequate humoral immune response in people living with HIV
por: Routy, Jean-Pierre, et al.
Publicado: (2022)

Human talent in geriatrics in Colombia and its relevance for the management of COVID-19
por: Gutiérrez Cortes, William Arbey, et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults
por: Cox, Lynne S, et al.
Publicado: (2020)

Suspending methotrexate for 2 weeks after COVID-19 vaccination
por: Coates, Laura C, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria
por: Pike, Alexandra, et al.
Publicado: (2022)

COVID-19 and the anti-lessons of history
por: Peckham, Robert
Publicado: (2020)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Are COVID-19 vaccines safe in pregnancy?
por: Male, Victoria
Publicado: (2021)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

COVID-19 vaccines and women's security
por: Harman, Sophie, et al.
Publicado: (2021)

Adult-onset Still's disease following COVID-19 vaccination
por: Leone, Flavia, et al.
Publicado: (2021)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

COVID-19 vaccine results might inform malaria vaccine strategies
por: Abeywickrema, Movin, et al.
Publicado: (2022)

COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil
por: Fernandez, Michelle, et al.
Publicado: (2022)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Ensuring global access to COVID-19 vaccines
por: Yamey, Gavin, et al.
Publicado: (2020)

Optimizing safety surveillance for COVID-19 vaccines
por: Chandler, Rebecca E.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1j3dmebimtkggndqg7bi64m71i